Cargando…
Cardiotoxicity of Molecularly Targeted Agents
Cardiac toxicity of molecularly targeted cancer agents is increasingly recognized as a significant side effect of chemotherapy. These new potent therapies may not only affect the survival of cancer cells, but have the potential to adversely impact normal cardiac and vascular function. Unraveling the...
Autores principales: | Hedhli, Nadia, Russell, Kerry S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322440/ https://www.ncbi.nlm.nih.gov/pubmed/22758623 http://dx.doi.org/10.2174/157340311799960636 |
Ejemplares similares
-
Cardiotoxicity due to targeted anticancer agents: a growing challenge
por: Shah, Chintan P., et al.
Publicado: (2019) -
Molecular and cellular mechanisms of cardiotoxicity.
por: Kang, Y J
Publicado: (2001) -
Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents
por: Briasoulis, Alexandros, et al.
Publicado: (2022) -
Anthracycline-induced cardiotoxicity: From pathobiology to identification of molecular targets for nuclear imaging
por: Jong, Jeremy, et al.
Publicado: (2022) -
Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
por: Volkova, Maria, et al.
Publicado: (2011)